Sindrome.del.Ovario.Poliquistico

Inducción a la ovulación 143
28
Fatemi HM, Kolibianakis E, Tournaye H,
Camus M, Van Steirteghem AC, Devroey
P. Clomiphene citrate versus letrozole
for ovarian stimulation: a pilot study.
Reprod Biomed Online. 2003;7:543-56.
29
Al-Fozan H, Al-Khadouri M, Tan SL,
Tulandi T. A randomized trial of letrozole
versus clomiphene citrate in women
undergoing superovulation. Fertil Steril.
2004;82:1561-3.
30
Al-Omari WR, Sulaiman WR, Al-Hadithi
N. Comparison of two aromatase inhibitors
in women with clomiphene-resistant
polycycstic ovary syndrome. Int J
Gynaecol Obstet. 2004;85:289-91.
31
Braat D. Pulsatile gonadotrophin-releasing
hormone (GnRH) treatment
in hypogonadotrophic amenorrhoea.
Reprod Med Review. 1993;2:119-28.
32
Bayram N, Van Wely M, Vandekerckhove
P, Lilford R, Van Der Veen F. Pulsatile
luteinising hormone releasing hormone
for ovulation induction in subfertility
associated with polycystic ovary syndrome.
Cochrane Database Syst Rev.
2000;(2):CD000412. Review. Update:
Cochrane Database Syst Rev. 2004;(1):
CD000412.
33
Yarali H, Zeyneloglu HB. Gonadotrophin
treatment in patients with polycystic
ovary syndrome. Reprod Biomed Online.
2004;8:528-37.
34
ESHRE Capri Workshop Group. Monoovulatory
cycles: a key goal in profertility
programmes. Human Reprod Update.
2003;3:263-74.
35
Wang CHF, Gemzell C. The use of
human gonadotropins for the induction
of ovulation in women with polycystic
ovarian disease. Fertil Steril. 1980;33:
479-86.
36
Seibel MM, McArdle C, Smith D, Taymor
ML. Ovulation induction in polycystic
ovary syndrome with urinary folliclestimulating
hormone or human menopausal
gonadotropin. Fertil Steril. 1985;
43:703-8.
37
Claman P, Seibel AM, McArdle C, Berger
M, Taymor ML. Comparison of intermediate-dose
purified urinary folliclestimulating
hormone with and without
human chorionic gonadotropin for ovulation
induction in polycystic ovarian
disease. Fertil Steril. 1986;46:518-21.
38
Polson DW, Mason HD, Saldahna MBY,
Franks S. Ovulation of a single dominant
follicle during treatment with low-dose
pulsatile follicle stimulating hormone in
women with polycystic ovary syndrome.
Clin Endocrinol. 1987;26:205-12.
39
Kamrava MM, Seibel MM, Berger MJ,
Thompson I, Taymor ML. Reversal of
persistent anovulation in polycystic ovarian
disease by administration of chronic
low-dose follicle-stimulation hormone.
Fertil Steril. 1992;4:520-3.
40
Buvat J, Buvat-Herbaut M, Marcolin G,
Dehaene JL, Verbecq P, Renouard O.
Purified follicle-stimulating hormone in
polycystic ovary syndrome: slow administration
is safer and more effective.
Fertil Steril. 1989;52:553-9.
41
Shoham Z, Patel A, Jacobs HS. Polycystic
ovarian syndrome: safety and effectiveness
of stepwise and low-dose administration
of purified follicle-stimulating
hormone. Fertil Steril. 1991;6:1051-6.
42
Hamilton-Fairy D, Kiddy D, Watson H,
Sagle M, Franks S. Low dose gonadotrophin
therapy for induction of ovulation
in 100 women with PCOS. Human
Reprod. 1991;6:1095-9.
43
Tur R, Barri PN, Coroleu B, Buxaderas
R, Martínez F, Balasch J. Risk factors
for high-order multiple implantation
after ovarian stimulation with gonadotrophins:
evidence from a large series
of 1.878 consecutive pregnancies in a
single centre. Hum Reprod. 2001;16:
2124-9.
44
Tur R, Barri PN, Coroleu B, Buxaderas
R, Parera N, Balasch J. Use of a prediction
model for high-order multiple
implantation after ovarian stimulation
with gonadotropins. Fertil Steril. 2005;
83:116-21.
45
Homburg R, Levy T, Ben-Rafael Z. A
comparative prospective study of con-